BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 16682274)

  • 1. Lysophospholipids as mediators of immunity.
    Lin DA; Boyce JA
    Adv Immunol; 2006; 89():141-67. PubMed ID: 16682274
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Unfolding the pathophysiological role of bioactive lysophospholipids.
    Xu Y; Xiao YJ; Zhu K; Baudhuin LM; Lu J; Hong G; Kim KS; Cristina KL; Song L; S Williams F; Elson P; Markman M; Belinson J
    Curr Drug Targets Immune Endocr Metabol Disord; 2003 Mar; 3(1):23-32. PubMed ID: 12570723
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Emerging lysophospholipid mediators, lysophosphatidylserine, lysophosphatidylthreonine, lysophosphatidylethanolamine and lysophosphatidylglycerol.
    Makide K; Kitamura H; Sato Y; Okutani M; Aoki J
    Prostaglandins Other Lipid Mediat; 2009 Sep; 89(3-4):135-9. PubMed ID: 19427394
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sphingosine 1-phosphate and its type 1 G protein-coupled receptor: trophic support and functional regulation of T lymphocytes.
    Goetzl EJ; Gräler MH
    J Leukoc Biol; 2004 Jul; 76(1):30-5. PubMed ID: 14982946
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biological effects of lysophospholipids.
    Rivera R; Chun J
    Rev Physiol Biochem Pharmacol; 2008; 160():25-46. PubMed ID: 18481029
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lysophospholipids in development: Miles apart and edging in.
    Saba JD
    J Cell Biochem; 2004 Aug; 92(5):967-92. PubMed ID: 15258919
    [TBL] [Abstract][Full Text] [Related]  

  • 7. IL-6 and IL-8 release is mediated via multiple signaling pathways after stimulating dendritic cells with lysophospholipids.
    Oz-Arslan D; Rüscher W; Myrtek D; Ziemer M; Jin Y; Damaj BB; Sorichter S; Idzko M; Norgauer J; Maghazachi AA
    J Leukoc Biol; 2006 Aug; 80(2):287-97. PubMed ID: 16769764
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lysophospholipid growth factors and their G protein-coupled receptors in immunity, coronary artery disease, and cancer.
    Goetzl EJ; Graeler M; Huang MC; Shankar G
    ScientificWorldJournal; 2002 Feb; 2():324-38. PubMed ID: 12806020
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lysophospholipids--receptor revelations.
    Hla T; Lee MJ; Ancellin N; Paik JH; Kluk MJ
    Science; 2001 Nov; 294(5548):1875-8. PubMed ID: 11729304
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lysophospholipid signaling in the function and pathology of the reproductive system.
    Ye X
    Hum Reprod Update; 2008; 14(5):519-36. PubMed ID: 18562325
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regulation of stem cell pluripotency and neural differentiation by lysophospholipids.
    Pitson SM; Pébay A
    Neurosignals; 2009; 17(4):242-54. PubMed ID: 19816061
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stem cell regulation by lysophospholipids.
    Pébay A; Bonder CS; Pitson SM
    Prostaglandins Other Lipid Mediat; 2007 Nov; 84(3-4):83-97. PubMed ID: 17991611
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New intercellular lipid mediators and their GPCRs: an update.
    Im DS
    Prostaglandins Other Lipid Mediat; 2009 Sep; 89(3-4):53-6. PubMed ID: 19442546
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lysophospholipids and their G protein-coupled receptors in inflammation and immunity.
    Gräler MH; Goetzl EJ
    Biochim Biophys Acta; 2002 May; 1582(1-3):168-74. PubMed ID: 12069825
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tipping the gatekeeper: S1P regulation of endothelial barrier function.
    Rosen H; Sanna MG; Cahalan SM; Gonzalez-Cabrera PJ
    Trends Immunol; 2007 Mar; 28(3):102-7. PubMed ID: 17276731
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel bioactive glycerol-based lysophospholipids: new data -- new insight into their function.
    Grzelczyk A; Gendaszewska-Darmach E
    Biochimie; 2013 Apr; 95(4):667-79. PubMed ID: 23089136
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Involvement of sphingosine 1-phosphate (S1P) receptor type 1 and type 4 in migratory response of mouse T cells toward S1P.
    Matsuyuki H; Maeda Y; Yano K; Sugahara K; Chiba K; Kohno T; Igarashi Y
    Cell Mol Immunol; 2006 Dec; 3(6):429-37. PubMed ID: 17257496
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lysophospholipid activation of G protein-coupled receptors.
    Mutoh T; Chun J
    Subcell Biochem; 2008; 49():269-97. PubMed ID: 18751915
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sphingosine-1-phosphate signaling in the cardiovascular system.
    Peters SL; Alewijnse AE
    Curr Opin Pharmacol; 2007 Apr; 7(2):186-92. PubMed ID: 17280869
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lysophosphatidic acid production and action: validated targets in cancer?
    Umezu-Goto M; Tanyi J; Lahad J; Liu S; Yu S; Lapushin R; Hasegawa Y; Lu Y; Trost R; Bevers T; Jonasch E; Aldape K; Liu J; James RD; Ferguson CG; Xu Y; Prestwich GD; Mills GB
    J Cell Biochem; 2004 Aug; 92(6):1115-40. PubMed ID: 15258897
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.